BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 19 filers reported holding BICYCLE THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,259 | +13.6% | 3,348 | +44.3% | 0.00% | – |
| Q2 2023 | $59,204 | +162.6% | 2,320 | +118.9% | 0.00% | – |
| Q1 2023 | $22,546 | -40.7% | 1,060 | -19.1% | 0.00% | – |
| Q4 2022 | $38,000 | +15.2% | 1,310 | -7.1% | 0.00% | – |
| Q3 2022 | $33,000 | +106.2% | 1,410 | +48.4% | 0.00% | – |
| Q2 2022 | $16,000 | -90.9% | 950 | -76.5% | 0.00% | – |
| Q1 2022 | $176,000 | -33.3% | 4,039 | -6.8% | 0.00% | – |
| Q4 2021 | $264,000 | +25.7% | 4,334 | -14.4% | 0.00% | – |
| Q3 2021 | $210,000 | -62.0% | 5,064 | -72.2% | 0.00% | -100.0% |
| Q2 2021 | $552,000 | +18.2% | 18,196 | +16.4% | 0.00% | 0.0% |
| Q1 2021 | $467,000 | +17.6% | 15,627 | -29.3% | 0.00% | 0.0% |
| Q4 2020 | $397,000 | -20.1% | 22,112 | -15.3% | 0.00% | 0.0% |
| Q3 2020 | $497,000 | -7.4% | 26,100 | -23.5% | 0.00% | -50.0% |
| Q2 2020 | $537,000 | +53600.0% | 34,100 | +34000.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,915,274 | $57,209,000 | 21.43% |
| Atlas Venture Advisors, Inc. | 612,696 | $18,301,000 | 3.38% |
| Logos Global Management LP | 800,000 | $23,896,000 | 2.33% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,957,961 | $58,484,000 | 1.28% |
| Ghost Tree Capital, LLC | 150,000 | $4,481,000 | 1.05% |
| Parkman Healthcare Partners LLC | 75,454 | $2,254,000 | 0.52% |
| MOODY ALDRICH PARTNERS LLC | 74,060 | $2,212,000 | 0.32% |
| Point72 Asset Management, L.P. | 1,577,493 | $47,120,000 | 0.22% |
| Eventide Asset Management | 411,838 | $12,302,000 | 0.18% |
| SAMLYN CAPITAL, LLC | 437,728 | $13,076,000 | 0.18% |